GC34605
GSK840
Also known as tert-butyl 2-[4-[5-(methylcarbamoyl)benzimidazol-1-yl]phenyl]acetate
GSK840 (GSK'840) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 0·9 nM, and inhibits kinase activity with an IC50 of 0·3 nM
ChemicalCAS2361146-30-5MW365.43FormulaC21H23N3O3
- CAS number
- 2361146-30-5
- Molecular weight
- 365.43
- Formula
- C21H23N3O3
- Solubility
- 110 mg/mL in DMSO
- InChIKey
- UGTLDBJIOSYXRR-UHFFFAOYSA-N
- Catalogue number
- GC34605
- Brand
- GLPBIO
Computed properties PubChem CID 138377545 · XLogP 3.1 · TPSA 73.2 Ų · H-bond donors 1
- XLogP
- 3.1
- TPSA
- 73.2 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 6
- Heavy atoms
- 27
SMILES CC(C)(C)OC(=O)CC1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)C(=O)NC
Computed descriptors from PubChem (CID 138377545), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il